Paper32034799
Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition.
Sanyal A and 8 others. Mov Disord, 2020. Cited by 95 papers, by iCite.
Cite this record
ConductScience Library. Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition. Papers, record 32034799. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32034799
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gaucher Disease | Major topic |
| Parkinson Disease | Major topic |
| Animals | |
| Astrocytes | |
| Glucosylceramidase | |
| Humans | |
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | |
| Lysosomes | |
| Mice | |
| Mutation |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 NS092122 | NINDS NIH HHS | United States | R01NS092122 | PubMed and NIH | NIH RePORTER |
| R01 NS110188 | NINDS NIH HHS | United States | R01NS110188 | PubMed and NIH | NIH RePORTER |
| American Parkinson Disease Association | International | PubMed | PubMed | ||
| NS069949 | NINDS NIH HHS | United States | R21NS069949 | PubMed and NIH | NIH RePORTER |
| R01 NS065013 | NINDS NIH HHS | United States | R01NS065013 | PubMed | NIH RePORTER |
| NS092122 | NINDS NIH HHS | United States | R01NS092122 | PubMed and NIH | NIH RePORTER |
| R21 NS069949 | NINDS NIH HHS | United States | R21NS069949 | PubMed and NIH | NIH RePORTER |
| NS110188 | NINDS NIH HHS | United States | R01NS110188 | PubMed and NIH | NIH RePORTER |
| UL1 TR002378 | NCATS NIH HHS | United States | UL1TR002378 | PubMed | NIH RePORTER |
| Michael J. Fox Foundation for Parkinson's Research | International | PubMed | PubMed |
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26848562 | Atp13a2 Deficiency Aggravates Astrocyte-Mediated Neuroinflammation via NLRP3 Inflammasome Activation. | CNS Neurosci Ther | 2016 | https://conductscience.org/library/papers/26848562 | PubMed |
| 2 | 25284317 | The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease. | Neuroscience | 2015 | https://conductscience.org/library/papers/25284317 | PubMed |
| 3 | 25122523 | Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates. | Nat Protoc | 2014 | https://conductscience.org/library/papers/25122523 | PubMed |
| 4 | 1696426 | A comparison of antiarrhythmic drugs for the suppression of ventricular ectopic depolarizations: a meta-analysis. | Am Heart J | 1990 | https://conductscience.org/library/papers/1696426 | PubMed |
| 5 | 25360523 | LRRK2 transport is regulated by its novel interacting partner Rab32. | PLoS One | 2014 | https://conductscience.org/library/papers/25360523 | PubMed |
| 6 | 30573413 | Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations. | Parkinsonism Relat Disord | 2019 | https://conductscience.org/library/papers/30573413 | PubMed |
| 7 | 26117366 | Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. | Brain | 2015 | https://conductscience.org/library/papers/26117366 | PubMed |
| 8 | 2508065 | Comparison of RNase A, a chemical cleavage and GC-clamped denaturing gradient gel electrophoresis for the detection of mutations in exon 9 of the human acid beta-glucosidase gene. | Nucleic Acids Res | 1989 | https://conductscience.org/library/papers/2508065 | PubMed |
| 9 | 12706236 | Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. | Brain Res | 2003 | https://conductscience.org/library/papers/12706236 | PubMed |
| 10 | 18022370 | LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. | Cell | 2007 | https://conductscience.org/library/papers/18022370 | PubMed |
| 11 | 25126989 | ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease. | Chem Biol | 2014 | https://conductscience.org/library/papers/25126989 | PubMed |
| 12 | 19549006 | Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. | J Neurochem | 2009 | https://conductscience.org/library/papers/19549006 | PubMed |
| 13 | 2502917 | Gaucher disease: molecular heterogeneity and phenotype-genotype correlations. | Am J Hum Genet | 1989 | https://conductscience.org/library/papers/2502917 | PubMed |
| 14 | 22914327 | IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. | Cell Death Dis | 2012 | https://conductscience.org/library/papers/22914327 | PubMed |
| 15 | 29800472 | Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo. | Brain | 2018 | https://conductscience.org/library/papers/29800472 | PubMed |
| 16 | 10796875 | Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. | Am J Hum Genet | 2000 | https://conductscience.org/library/papers/10796875 | PubMed |
| 17 | 23169921 | S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway. | Brain | 2012 | https://conductscience.org/library/papers/23169921 | PubMed |
| 18 | 30209220 | LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30209220 | PubMed |
| 19 | 19296921 | Neuroinflammation in Parkinson's disease: a target for neuroprotection? | Lancet Neurol | 2009 | https://conductscience.org/library/papers/19296921 | PubMed |
| 20 | 25186741 | An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. | J Neurosci | 2014 | https://conductscience.org/library/papers/25186741 | PubMed |
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42902384 | Parkinson's disease LRRK2 mutations dysregulate iron homeostasis and promote oxidative stress and ferroptosis in human neurons and astrocytes. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42902384 | PubMed |
| 42768228 | Convergent Astrocytic Failure in Parkinson's Disease: A System-Level Model of Pathogenesis and Treatment. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42768228 | PubMed |
| 42734724 | Astrocytes in Neurodegeneration: Spatial States, Crosstalk, and Emerging Therapies. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42734724 | PubMed |
| 42651749 | Distinct Transcriptomic Signatures of HIV-1 Tat and gp120 Uncover Differential Neuroimmune Vulnerability in a Gba1-Deficient Synucleinopathy Model. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42651749 | PubMed |
| 42599550 | Astrocytes orchestrate neuroprotection and pathogenesis via bidirectional neuronal interactions in Parkinson's disease. | J Physiol Biochem | 2026 | https://conductscience.org/library/papers/42599550 | PubMed |
| 42582587 | Altered synaptic and astrocytic proteins in Lewy body disorders associated with GBA mutations. | Brain Commun | 2026 | https://conductscience.org/library/papers/42582587 | PubMed |
| 42443387 | Astrocytic lipid dysregulation as an early driver of neurodegeneration. | Nat Rev Neurol | 2026 | https://conductscience.org/library/papers/42443387 | PubMed |
| 42106708 | Neuroinflammation-induced downregulation of RAB7 in murine astrocytes disrupts endo-lysosomal homeostasis and induces astrogliosis. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42106708 | PubMed |
| 41935068 | Wdfy3-dependent autophagy impairment recapitulates presymptomatic neurodegenerative signatures in mice. | Sci Rep | 2026 | https://conductscience.org/library/papers/41935068 | PubMed |
| 41786767 | LRRK2 kinase mediates increased GCase activity in microglia in response to IFNγ-induced proinflammatory stimulation. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/41786767 | PubMed |
| 41467444 | Interplay of GBA1 with lysosomal dysfunction and inflammation in Parkinson's disease. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/41467444 | PubMed |
| 40903956 | Neurodegenerative diseases and immune system: From pathogenic mechanism to therapy. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/40903956 | PubMed |
| 40629324 | Recent advances in targeting LRRK2 for Parkinson's disease treatment. | J Transl Med | 2025 | https://conductscience.org/library/papers/40629324 | PubMed |
| 40545554 | Differences in the soluble and insoluble proteome between primary tauopathies. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40545554 | PubMed |
| 40450319 | Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death. | Behav Brain Funct | 2025 | https://conductscience.org/library/papers/40450319 | PubMed |
| 40332757 | Identification of Novel Mutations in Patients Affected by Gaucher Disease. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332757 | PubMed |
| 40128809 | Immune cell metabolic dysfunction in Parkinson's disease. | Mol Neurodegener | 2025 | https://conductscience.org/library/papers/40128809 | PubMed |
| 39456137 | Astrocyte-Mediated Neuroinflammation in Neurological Conditions. | Biomolecules | 2024 | https://conductscience.org/library/papers/39456137 | PubMed |
| 39267121 | Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease. | Transl Neurodegener | 2024 | https://conductscience.org/library/papers/39267121 | PubMed |
| 38976650 | Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activation. | Brain | 2024 | https://conductscience.org/library/papers/38976650 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32034799
GET https://conductscience.org/api/papers/v1/32034799/references?page=2